journal article·2020-06-03Open access

A 2,5-Dihydroxybenzoic Acid–Gelatin Conjugate Inhibits the Basal and Hsp90-Stimulated Migration and Invasion of Tumor Cells

Anastasiya V. Snigireva, Oleg S. Morenkov, Yuri Y. Skarga, Alexander V. Lisov, Zoya A. Lisova, Alexey A. Leontievsky, Mariya A. Zhmurina, Viktoria S. Petrenko, Veronika V. Vrublevskaya

Abstract

The extracellular cell surface-associated and soluble heat shock protein 90 (Hsp90) is known to participate in the migration and invasion of tumor cells. Earlier, we demonstrated that plasma membrane-associated heparan sulfate proteoglycans (HSPGs) bind the extracellular Hsp90 and thereby promote the Hsp90-mediated motility of tumor cells. Here, we showed that a conjugate of 2,5-dihydroxybenzoic acid with gelatin (2,5-DHBA–gelatin), a synthetic polymer with heparin-like properties, suppressed the basal (unstimulated) migration and invasion of human glioblastoma A-172 and fibrosarcoma HT1080 cells, which was accompanied by the detachment of a fraction of Hsp90 from cell surface HSPGs. The polymeric conjugate also inhibited the migration/invasion of cells stimulated by exogenous soluble native Hsp90, which correlated with the inhibition of the attachment of soluble Hsp90 to cell surface HSPGs. The action of the 2,5-DHBA–gelatin conjugate on the motility of A-172 and HT1080 cells was similar to that of heparin. The results demonstrate a potential of the 2,5-DHBA–gelatin polymer for the development of antimetastatic drugs targeting cell motility and a possible role of extracellular Hsp90 in the suppression of the migration and invasion of tumor cells mediated by the 2,5-DHBA–gelatin conjugate and heparin.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Heat shock proteins research · Proteoglycans and glycosaminoglycans research · Veterinary Equine Medical Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Cell Biophysics, Federal Research Center “Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences”, 142290 Pushchino, Moscow Region, Russia

Skryabin Institute of Biochemistry and Physiology of Microorganisms, Federal Research Center “Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences”, 142290 Pushchino, Moscow Region, Russia

References (58)

Show source-provided references
1. Targeting tumor cell motility as a strategy against invasion and metastasis10.1016/j.tips.2013.03.001 ↗
2. Heparan sulfate proteoglycans10.1101/cshperspect.a004952 ↗
3. Fell-Muir lecture: Heparan sulphate and the art of cell regulation: A polymer chain conducts the protein orchestra10.1111/iep.12135 ↗
4. Morla, S. (2019). Glycosaminoglycans and glycosaminoglycan mimetics in cancer and inflammation. Int. J. Mol. Sci., 20.10.3390/ijms20081963 ↗
5. Heparin as an anticancer therapeutic10.1517/13543784.17.7.1029 ↗
6. Heparin as an inhibitor of cancer progression10.1016/S1877-1173(10)93014-7 ↗
7. The antineoplastic effect of low-molecular-weight heparins-A literature review
8. Zhou, H., Roy, S., Cochran, E., Zouaoui, R., Chu, C.L., Duffner, J., Zhao, G., Smith, S., Galcheva-Gargova, Z., and Karlgren, J. (2011). M402, a novel Heparan sulfate mimetic, targets multiple pathways implicated in tumor progression and metastasis. PLoS ONE, 6.10.1371/journal.pone.0021106 ↗
9. SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axis10.1158/1078-0432.CCR-10-2476 ↗
10. Dalteparin, a low-molecular-weight heparin, promotes angiogenesis mediated by heparin-binding VEGF-A in vivo10.1111/j.1600-0463.2010.02635.x ↗
11. Selective antimetastatic effect of heparins in preclinical human melanoma models is based on inhibition of migration and microvascular arrest10.1007/s10585-005-3859-6 ↗
12. The complex effects of heparins on cancer progression and metastasis in experimental studies
13. Heparin inhibition of selectin-mediated interactions during the hematogenous phase of carcinoma metastasis: Rationale for clinical studies in humans10.1055/s-2002-20564 ↗
14. Modulatory effects of heparin and short-length oligosaccharides of heparin on the metastasis and growth of LMD MDA-MB 231 breast cancer cells in vivo10.1038/sj.bjc.6603928 ↗
15. Differential metastasis inhibition by clinically relevant levels of heparins-correlation with selectin inhibition, not antithrombotic activity10.1158/1078-0432.CCR-05-1131 ↗
16. Structure, function and regulation of the hsp90 machinery10.4103/2319-4170.113230 ↗
17. Induction of Hsp90 protein expression in malignant melanomas and melanoma metastases10.1111/j.0906-6705.2004.00114.x ↗
18. Secretion of heat shock protein-90 (Hsp90) by normal cells under stress or by tumor cells during invasion: Why?
19. Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness10.1038/ncb1131 ↗
20. McCready, J., Sims, J.D., Chan, D., and Jay, D.G. (2010). Secretion of extracellular hsp90α via exosomes increases cancer cell motility: A role for plasminogen activation. BMC Cancer, 10.10.1186/1471-2407-10-294 ↗
21. A critical role for HSP90 in cancer cell invasion involves interaction with the extracellular domain of HER-210.1074/jbc.M701803200 ↗
22. Monoclonal antibody 4C5 immunostains human melanomas and inhibits melanoma cell invasion and metastasis10.1158/1078-0432.CCR-06-1585 ↗
23. The regulatory mechanism of HSP90α secretion and its function in tumor malignancy10.1073/pnas.0908151106 ↗
24. A small molecule cell-impermeant Hsp90 antagonist inhibits tumor cell motility and invasion10.1038/sj.onc.1210897 ↗
25. An impermeant ganetespib analog inhibits extracellular Hsp90-mediated cancer cell migration that involves lysyl oxidase 2-like protein10.3390/cancers6021031 ↗
26. A potentially common peptide target in secreted heat shock protein-90α for hypoxia-inducible factor-1α-positive tumors10.1091/mbc.e11-06-0575 ↗
27. Hectd1 regulates intracellular localization and secretion of Hsp90 to control cellular behavior of the cranial mesenchyme10.1083/jcb.201105101 ↗
28. The regulatory mechanism of extracellular Hsp90α on matrix metalloproteinase-2 processing and tumor angiogenesis10.1074/jbc.M110.181941 ↗
29. Cell surface heparan sulfate proteoglycans are involved in the binding of Hsp90α and Hsp90β to the cell plasma membrane10.1080/19336918.2015.1103421 ↗
30. Cell surface heparan sulfate proteoglycans are involved in the extracellular Hsp90-stimulated migration and invasion of cancer cells10.1007/s12192-018-0955-5 ↗
31. A 2,5-dihydroxybenzoic acid-gelatin conjugate: The synthesis, antiviral activity and mechanism of antiviral action against two alphaherpesviruses10.3390/v7102878 ↗
32. Combinatorial attack on multistep oncogenesis by inhibiting the Hsp90 molecular chaperone10.1016/j.canlet.2003.08.032 ↗
33. Secreted heat shock protein 90α induces colorectal cancer cell invasion through CD91/LRP-1 and NF-kappaB-mediated integrin αV expression10.1074/jbc.M110.139345 ↗
34. Transforming growth factor alpha (TGFalpha)-stimulated secretion of HSP90alpha: Using the receptor LRP-1/CD91 to promote human skin cell migration against a TGFbeta-rich environment during wound healing10.1128/MCB.01287-07 ↗
35. Gopal, U., Bohonowych, J.E., Lema-Tome, C., Liu, A., Garrett-Mayer, E., Wang, B., and Isaacs, J.S. (2011). A novel extracellular Hsp90 mediated co-receptor function for LRP1 regulates EphA2 dependent glioblastoma cell invasion. PLoS ONE, 6.10.1371/journal.pone.0017649 ↗
36. Secreted Hsp90 is a novel regulator of the epithelial to mesenchymal transition (EMT) in prostate cancer10.1074/jbc.M112.389015 ↗
37. Extracellular heat shock protein 90 signals through subdomain II and the NPVY motif of LRP-1 receptor to Akt1 and Akt2: A circuit essential for promoting skin cell migration in vitro and wound healing in vivo10.1128/MCB.00559-13 ↗
38. Transactivation of the epidermal growth factor receptor by heat shock protein 90 via toll-like receptor 4 contributes to the migration of glioblastoma cells10.1074/jbc.M110.154823 ↗
39. Extracellular heat shock protein-90alpha: Linking hypoxia to skin cell motility and wound healing10.1038/sj.emboj.7601579 ↗
40. Extracellular Hsp90 (eHsp90) as the actual target in clinical trials: Intentionally or unintentionally10.1016/B978-0-12-407697-6.00005-2 ↗
41. Secreted heat shock protein 90α (Hsp90α) induces nuclear factor-κb-mediated TCF12 protein expression to down-regulate E-cadherin and to enhance colorectal cancer cell migration and invasion10.1074/jbc.M112.437897 ↗
42. Anticancer activity of a quercetin-based polymer towards HeLa cancer cells
43. Synthetic polymers with intrinsic anticancer activity10.1177/088391159100600205 ↗
44. Synthesis, characterization, and antitumor activity of poly(maleic anhydride-co-vinyl acetate-co-acrylic acid)10.1002/app.21834 ↗
45. Biological activity of a gallic acid-gelatin conjugate10.1021/bm100760x ↗
46. Antiproliferative effect of synthetic lignin against human breast cancer and normal fetal lung cell lines. Potency of low molecular weight fractions
47. Antitumor activity of polycarboxylic acid polymers10.1080/00222338508056638 ↗
48. Chondroitin sulfate and heparan sulfate-containing proteoglycans are both partners and targets of basic fibroblast growth factor-mediated proliferation in human metastatic melanoma cell lines10.1016/j.biocel.2007.06.019 ↗
49. Chondroitin sulfate A chains enhance platelet derived growth factor-mediated signalling in fibrosarcoma cells10.1016/j.biocel.2006.06.006 ↗
50. Evaluation of antiproliferative and antimetastatic effects of heparin and erythropoietin on B16f10 melanoma cell line
51. Heparin regulates colon cancer cell growth through p38 mitogen-activated protein kinase signalling10.1111/j.1365-2184.2009.00649.x ↗
52. Growth-modulatory effects of heparin and VEGF165 on the choriocarcinoma cell-line JEG-3 and its expression of heparanase
53. Collective cell migration in morphogenesis, regeneration and cancer10.1038/nrm2720 ↗
54. Involvement of cell surface HSP90 in cell migration reveals a novel role in the developing nervous system10.1074/jbc.M405486200 ↗
55. Heparan sulfate proteoglycans: Structure, protein interactions and cell signaling10.1590/S0001-37652009000300007 ↗
56. Two laccase isoforms of the basidiomycete Cerrena unicolor VKMF-3196. Induction, isolation and properties10.1002/jobm.200900382 ↗
57. Purification of the 90 kDa heat shock protein (hsp90) and simultaneous purification of hsp70/hsc70, hsp90 and hsp96 from mammalian tissues and cells using thiophilic interaction chromatography10.1002/bmc.1245 ↗
58. Sittampalam, G.S., Grossman, A., and Brimacombe, K. (2004). Cell viability assays, Assay Guidance Manual [Internet].